Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
05/2005
05/25/2005CN1618791A New synthesis method of alipirazole
05/25/2005CN1203060C Pyridine derivatives, its composition and use
05/25/2005CN1202864C Use of CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
05/24/2005US6897317 For therapy of arteriosclerosis and dyslipidaemias
05/24/2005US6897316 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents
05/24/2005US6897315 Method for producing 8-methoxy-quinolinecarboxylic acids
05/24/2005US6897224 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
05/24/2005US6897219 Central nervous system diosrders; analgesics; antiinflammatory agents
05/19/2005WO2005044802A2 Tetrahydro-quinolinylurea derivatives as vrl antagonists
05/19/2005WO2005044788A1 Urea derivative and process for producing the same
05/19/2005WO2005030140A3 C-met modulators and methods of use
05/19/2005WO2005028421A3 Process for the synthesis of 6-amino-4-[(3-chloro-4-fluorophenyl)amino]-7-ethoxy-quinoline-3-carbonitrile
05/19/2005US20050107612 Process for preparation of montelukast and its salts
05/19/2005US20050107427 Benzyl urea and thiourea derivatives
05/19/2005US20050107426 Solid-state montelukast
05/19/2005US20050107423 Quinolone antibiotics such as 1-Cyclopropyl-6-fluoro-7-(4-hydroxy-hexahydro-cyclopenta[c]pyrrol-2-yl)-8-methyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, used for treating gramnegative or grampositive bacterial infection in mammals
05/19/2005US20050107410 Compound possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
05/19/2005US20050107409 drugs such as 3-{[7-(2,5-dihydropyrrol-1-yl-carbonyl)-quinazolin-4-yl]aminomethyl}-4-hydroxy-benzamidine, used as anticoagulants
05/19/2005US20050107388 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain
05/19/2005US20050107381 e.g. 2-[2-(3,5-Difluoro-phenyl)-acetylamino]-N-pyridin-2-yl-butyramide; inhibiting A beta -production; Alzheimer's disease, hereditary cerebral hemorrhage with amyloidosis, cerebral amyloid angiopathy, a prion-mediated disease, inclusion body myositis, stroke, multiple sclerosis and Down's Syndrome
05/19/2005US20050107372 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators
05/19/2005DE10347386A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors
05/19/2005CA2545109A1 Tetrahydro-quinolinylurea derivatives
05/18/2005EP1530564A2 Compounds derived from aryl carbamates, preparation thereof and uses of same
05/18/2005EP1430030B1 N-type calcium channel antagonists for the treatment of pain
05/18/2005CN1617865A Phenylalkynes
05/18/2005CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/18/2005CN1617851A Naphthol derivative and charge control agent comprising the same
05/18/2005CN1616455A Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate
05/18/2005CN1202084C Fused benzene heterocycle derivatives and utilization thereof
05/17/2005US6894166 Dichlorinated heterocyclic compounds and methods of synthesis
05/17/2005US6894044 Treatment of depression, anxiety, psychosis, obesity, pain, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, movement disorders, respiratory diseases, inflammatory diseases, neuropathy, immune disorders, etc.
05/17/2005US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine
05/12/2005WO2005043124A2 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors
05/12/2005WO2005042712A2 Heterocyclic compounds and methods of making and using thereof
05/12/2005WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005WO2005042498A2 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/12/2005WO2005041970A1 Process for making sterile aripiprazole of desired mean particle size
05/12/2005WO2004073628A3 Novel compounds
05/12/2005WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
05/12/2005WO2004026836A8 1-pyridin-4-yl-urea derivatives
05/12/2005US20050101807 Method for isomerizing allyl alcohols
05/12/2005US20050101780 Enzyme inhibitors for treatment of cancer leukemia; e.g. bosutinib
05/12/2005US20050101630 4-Anilino-, phenoxy-, or phenylthio-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes
05/12/2005US20050101590 Cannabinoid receptor agonists
05/12/2005US20050101569 Methods and compositions for selectin inhibition
05/12/2005US20050101568 Methods and compositions for selectin inhibition
05/12/2005CA2543248A1 Process for making sterile aripiprazole of desired mean particle size
05/12/2005CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005CA2540460A1 Heterocyclic compounds and methods of making and using thereof
05/12/2005CA2540342A1 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/11/2005EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals
05/11/2005EP1528924A1 Mch1r antagonists
05/11/2005CN1200938C Process for preparing 8-methoxy-quinolone
05/10/2005US6890926 Antitumor agents
05/10/2005CA2085816C Process for the manufacture of 2-alkoxymethylacrolein
05/06/2005WO2005040355A2 Tao kinase modulators and methods of use
05/06/2005WO2005040163A1 Heterocyclic compounds that block the effects of advanced glycation end products (age)
05/06/2005WO2005040125A1 Quinazoline derivatives for the treatment of herpesviral infections
05/06/2005WO2005040124A1 A polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline
05/06/2005WO2005040123A1 Solid-state montelukast
05/06/2005WO2005040102A2 Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
05/06/2005WO2005040100A1 Tetrahydro-naphthalene and urea derivatives
05/06/2005WO2005040095A1 Inhibitors of dipeptidyl peptidase iv
05/06/2005WO2005028443A3 Protein tyrosine kinase enzyme inhibitors
05/06/2005WO2005019240A3 Melanin concentrating hormone receptor antagonists
05/06/2005WO2005018573A3 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
05/06/2005WO2004112710A3 COMPOSITIONS AND METHODS FOR INHIBITING TGF-ß
05/06/2005WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
05/06/2005CA2542494A1 Tetrahydro-naphthalene and urea derivatives
05/06/2005CA2542064A1 Tao kinase modulators and methods of use
05/06/2005CA2541994A1 Solid-state montelukast
05/06/2005CA2540022A1 A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
05/05/2005US20050096316 Quinoline derivatives(2)
05/05/2005US20050096312 Antiserotonine agents; antidepressants; eating disorders; anxiolytic agents; sleep disorders; gastrointestinal disorders; cardiovascular disorders; muscular disorders; endocrine system diseases; muscular disorders; psychological disorders
05/05/2005US20050096309 For use as anticoagulant agents for therapy of thromboembolic disorders
05/05/2005US20050095457 Iridium complexes in electron transport layer of Light-emitting diodes; bright, efficient, stable; low temperature vacuum deposition and preventing decomposition
05/04/2005EP1527050A1 Quinoline derivatives and their use as mycobacterial inhibitors
05/04/2005EP1527049A2 Fused heterocyclic compounds as peptidase inhibitors
05/04/2005EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method
05/04/2005CN1612862A Preparation of an anhydrous quinoline-based EETP inhibitor by crystallization
05/04/2005CN1612735A Uses for anti-malarial therapeutic agents
05/04/2005CN1199951C Ciprofloxacin mandelate, ofloxacin mandelate and preparation process thereof
05/04/2005CN1199950C Quinolene derivatives as anti-inflammation agents
05/04/2005CN1199949C High-purity 8-hydroxyquinoline aluminium group compound, preparation method and use thereof
05/03/2005US6888032 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
05/03/2005US6887877 Viricide for hepatitis virus
05/03/2005US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors
05/03/2005CA2320388C Novel dihydroxyhexanoic acid derivatives
05/03/2005CA2208704C 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same
05/03/2005CA2133337C Compounds useful for treating allergic or inflammatory diseases
04/2005
04/28/2005WO2005037809A1 Substituted aryl cycloalkanol derivatives and methods of their use
04/28/2005WO2005037807A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
04/28/2005WO2005037283A1 Fused-aryl and heteroaryl derivatives and methods of their use
04/28/2005WO2005037279A1 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms
04/28/2005WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms)
04/28/2005WO2005007091A3 Histone deacetylase inhibitors and methods of use thereof
04/28/2005WO2004089293A3 Hydroxamic acid compounds and methods of use thereof
04/28/2005WO2004065539A3 Androgen receptor antagonists
04/28/2005WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation
1 ... 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 ... 277